Innovations in Drug Resistance
Drug resistance is a critical challenge in microbiology and onco-hematology, still representing a global threat to human health. More than half a century passed from the famous Luria–Delbrück fluctuation test, which demonstrated the development of bacterial resistance to phages. Nevertheless, Salvad...
Na minha lista:
| Formato: | Online |
|---|---|
| Idioma: | inglês |
| Publicado em: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Assuntos: | |
| Acesso em linha: | ONIX_20260416T142754_9783725852499_9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
| _version_ | 1869528316039397376 |
|---|---|
| collection | Directory of Open Access Books |
| description | Drug resistance is a critical challenge in microbiology and onco-hematology, still representing a global threat to human health. More than half a century passed from the famous Luria–Delbrück fluctuation test, which demonstrated the development of bacterial resistance to phages. Nevertheless, Salvador Luria’s pioneering work on drug resistance remains remarkably contemporary. Indeed, the scientific community continues to explore new strategies to hinder resistant pathogens spreading, as well as to optimize anticancer therapies to improve patients’ quality of life. Hence, the studies of Luria, Delbrück, and Hershey not only led to a Nobel Prize, but traced a new path in molecular genetics, which is still followed nowadays by scientists all over the world. This reprinted Special Issue, launched by Biomedicines Journal in honor of Prof. Salvador Luria, collects key contributions in drug resistance management, aiming to catch the latest advancements in this enticing research field. |
| format | Online |
| id | doab-20.500.12854ir-174704 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1747042026-04-16T16:02:15Z Innovations in Drug Resistance Bonifacio, Maria A. Mazzocca, Antonio Volpe, Anna Drug resistance Infections Cancer Bacteria Drug development Anticancer drugs Antibiotics Antifungal Candida Drug resistant pathogens Antibiotic resistance Chemoresistance Drug delivery Computational approaches Mutations Antibiofilm Salvador Luria Efflux pump inhibitors Salmonella LPS Claudin Chemotherapy E. coli S. aureus Nanoparticles Checkerboard assay Combinatorial Breast cancer Endometrial cancer Cancer-associated fibroblasts Ex vivo 3D model Tolerance Broth microdilution Human fungal pathogen Selenotherapy Virulence Genome editing CRISPR Cas9 Multiple myeloma Hydrogel Adjuvants Tumor microenvironment Co-culture Proliferation thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences Drug resistance is a critical challenge in microbiology and onco-hematology, still representing a global threat to human health. More than half a century passed from the famous Luria–Delbrück fluctuation test, which demonstrated the development of bacterial resistance to phages. Nevertheless, Salvador Luria’s pioneering work on drug resistance remains remarkably contemporary. Indeed, the scientific community continues to explore new strategies to hinder resistant pathogens spreading, as well as to optimize anticancer therapies to improve patients’ quality of life. Hence, the studies of Luria, Delbrück, and Hershey not only led to a Nobel Prize, but traced a new path in molecular genetics, which is still followed nowadays by scientists all over the world. This reprinted Special Issue, launched by Biomedicines Journal in honor of Prof. Salvador Luria, collects key contributions in drug resistance management, aiming to catch the latest advancements in this enticing research field. 2026-04-16T16:02:13Z 2026-04-16T16:02:13Z 2025 book ONIX_20260416T142754_9783725852499_9 9783725852499 9783725852505 https://directory.doabooks.org/handle/20.500.12854/174704 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/ https://mdpi.com/books/pdfview/book/11579 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-5250-5 10.3390/books978-3-7258-5250-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725852499 9783725852505 184 CH open access |
| spellingShingle | Drug resistance Infections Cancer Bacteria Drug development Anticancer drugs Antibiotics Antifungal Candida Drug resistant pathogens Antibiotic resistance Chemoresistance Drug delivery Computational approaches Mutations Antibiofilm Salvador Luria Efflux pump inhibitors Salmonella LPS Claudin Chemotherapy E. coli S. aureus Nanoparticles Checkerboard assay Combinatorial Breast cancer Endometrial cancer Cancer-associated fibroblasts Ex vivo 3D model Tolerance Broth microdilution Human fungal pathogen Selenotherapy Virulence Genome editing CRISPR Cas9 Multiple myeloma Hydrogel Adjuvants Tumor microenvironment Co-culture Proliferation thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences Innovations in Drug Resistance |
| title | Innovations in Drug Resistance |
| title_full | Innovations in Drug Resistance |
| title_fullStr | Innovations in Drug Resistance |
| title_full_unstemmed | Innovations in Drug Resistance |
| title_short | Innovations in Drug Resistance |
| title_sort | innovations in drug resistance |
| topic | Drug resistance Infections Cancer Bacteria Drug development Anticancer drugs Antibiotics Antifungal Candida Drug resistant pathogens Antibiotic resistance Chemoresistance Drug delivery Computational approaches Mutations Antibiofilm Salvador Luria Efflux pump inhibitors Salmonella LPS Claudin Chemotherapy E. coli S. aureus Nanoparticles Checkerboard assay Combinatorial Breast cancer Endometrial cancer Cancer-associated fibroblasts Ex vivo 3D model Tolerance Broth microdilution Human fungal pathogen Selenotherapy Virulence Genome editing CRISPR Cas9 Multiple myeloma Hydrogel Adjuvants Tumor microenvironment Co-culture Proliferation thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences |
| topic_facet | Drug resistance Infections Cancer Bacteria Drug development Anticancer drugs Antibiotics Antifungal Candida Drug resistant pathogens Antibiotic resistance Chemoresistance Drug delivery Computational approaches Mutations Antibiofilm Salvador Luria Efflux pump inhibitors Salmonella LPS Claudin Chemotherapy E. coli S. aureus Nanoparticles Checkerboard assay Combinatorial Breast cancer Endometrial cancer Cancer-associated fibroblasts Ex vivo 3D model Tolerance Broth microdilution Human fungal pathogen Selenotherapy Virulence Genome editing CRISPR Cas9 Multiple myeloma Hydrogel Adjuvants Tumor microenvironment Co-culture Proliferation thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences |
| url | ONIX_20260416T142754_9783725852499_9 |